Nishimoto N - Search Results

1

Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease.

Nishimoto N, Kanakura Y, Aozasa K, Johkoh T, Nakamura M, Nakano S, Nakano N, Ikeda Y, Sasaki T, Nishioka K, Hara M, Taguchi H, Kimura Y, Kato Y, Asaoku H, Kumagai S, Kodama F, Nakahara H, Hagihara K, Yoshizaki K, Kishimoto T. Nishimoto N, et al. Blood. 2005 Oct 15;106(8):2627-32. doi: 10.1182/blood-2004-12-4602. Epub 2005 Jul 5. Blood. 2005. PMID: 15998837 Free article. Clinical Trial.

2

[A humanized anti-IL-6 receptor antibody(MRA) in RA therapy].

Hagihara K, Nishimoto N, Yoshizaki K. Hagihara K, et al. Among authors: nishimoto n. Nihon Rinsho. 2002 Dec;60(12):2401-7. Nihon Rinsho. 2002. PMID: 12510369 Review. Japanese.

3

Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.

Nakahara H, Song J, Sugimoto M, Hagihara K, Kishimoto T, Yoshizaki K, Nishimoto N. Nakahara H, et al. Among authors: nishimoto n. Arthritis Rheum. 2003 Jun;48(6):1521-9. doi: 10.1002/art.11143. Arthritis Rheum. 2003. PMID: 12794819 Free article.

4

Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study.

Nishimoto N, Yoshizaki K, Maeda K, Kuritani T, Deguchi H, Sato B, Imai N, Suemura M, Kakehi T, Takagi N, Kishimoto T. Nishimoto N, et al. J Rheumatol. 2003 Jul;30(7):1426-35. J Rheumatol. 2003. PMID: 12858437 Clinical Trial.

5

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease.

Ito H, Takazoe M, Fukuda Y, Hibi T, Kusugami K, Andoh A, Matsumoto T, Yamamura T, Azuma J, Nishimoto N, Yoshizaki K, Shimoyama T, Kishimoto T. Ito H, et al. Among authors: nishimoto n. Gastroenterology. 2004 Apr;126(4):989-96; discussion 947. doi: 10.1053/j.gastro.2004.01.012. Gastroenterology. 2004. PMID: 15057738 Clinical Trial.

6

Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial.

Nishimoto N, Yoshizaki K, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Hashimoto J, Azuma J, Kishimoto T. Nishimoto N, et al. Arthritis Rheum. 2004 Jun;50(6):1761-9. doi: 10.1002/art.20303. Arthritis Rheum. 2004. PMID: 15188351 Free article. Clinical Trial.

7

Inhibition of IL-6 for the treatment of inflammatory diseases.

Nishimoto N, Kishimoto T. Nishimoto N, et al. Curr Opin Pharmacol. 2004 Aug;4(4):386-91. doi: 10.1016/j.coph.2004.03.005. Curr Opin Pharmacol. 2004. PMID: 15251133 Review.

8

Imaging of lesions in a murine rheumatoid arthritis model with a humanized anti-interleukin-6 receptor antibody.

Sugimoto K, Nishimoto N, Kishimoto T, Yoshizaki K, Nishimura T. Sugimoto K, et al. Among authors: nishimoto n. Ann Nucl Med. 2005 Jun;19(4):261-6. doi: 10.1007/BF02984617. Ann Nucl Med. 2005. PMID: 16097634

9

Interleukin 6: from bench to bedside.

Nishimoto N, Kishimoto T. Nishimoto N, et al. Nat Clin Pract Rheumatol. 2006 Nov;2(11):619-26. doi: 10.1038/ncprheum0338. Nat Clin Pract Rheumatol. 2006. PMID: 17075601 Review.

10

Anti-interleukin-6 receptor antibody therapy in rheumatic diseases.

Nakahara H, Nishimoto N. Nakahara H, et al. Among authors: nishimoto n. Endocr Metab Immune Disord Drug Targets. 2006 Dec;6(4):373-81. doi: 10.2174/187153006779025694. Endocr Metab Immune Disord Drug Targets. 2006. PMID: 17214583 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

361 results

Search Page

Filters